Tissue Regenix Group Plc (LSE:TRX) — Stock Price
Tissue Regenix Group Plc (LSE:TRX) is currently trading at GBX0.07 GBX, up 0.00% today. Over the past 52 weeks, shares have ranged between GBX0.07 and GBX30.00. This page tracks Tissue Regenix Group Plc's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see TRX stock market capitalisation.
Tissue Regenix Group Plc (TRX) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Tissue Regenix Group Plc's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Tissue Regenix Group Plc Income Statement — Revenue, Profit & Earnings by Year
Tissue Regenix Group Plc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | GBX28.65 Million | GBX29.49 Million | GBX24.48 Million | GBX19.75 Million | GBX12.83 Million |
| Cost of Revenue | GBX15.03 Million | GBX15.45 Million | GBX10.73 Million | GBX8.73 Million | GBX7.70 Million |
| Gross Profit | GBX13.62 Million | GBX14.04 Million | GBX9.14 Million | GBX5.63 Million | GBX5.13 Million |
| Research & Development | — | — | — | — | GBX744.10K |
| SG&A | GBX13.15 Million | GBX14.43 Million | GBX13.27 Million | GBX12.50 Million | GBX12.93 Million |
| Total Operating Expenses | GBX13.27 Million | GBX14.43 Million | GBX10.75 Million | GBX8.61 Million | GBX20.15 Million |
| Operating Income | GBX349.00K | GBX-394.00K | GBX-2.01 Million | GBX-4.38 Million | GBX-4.12 Million |
| EBITDA | GBX1.36 Million | GBX446.00K | GBX-1.04 Million | GBX-3.04 Million | GBX-9.03 Million |
| EBIT | GBX318.00K | GBX-531.00K | GBX-2.01 Million | GBX-4.02 Million | GBX-9.80 Million |
| Interest Expense | GBX882.00K | GBX1.14 Million | GBX741.00K | GBX692.00K | GBX571.00K |
| Income Before Tax | GBX-564.00K | GBX-1.67 Million | GBX-2.83 Million | GBX-5.14 Million | GBX-10.24 Million |
| Income Tax Expense | GBX289.00K | GBX-12.00K | GBX-232.00K | GBX-157.00K | GBX-533.00K |
| Net Income | GBX-713.00K | GBX-1.71 Million | GBX-2.69 Million | GBX-4.79 Million | GBX-9.71 Million |
Tissue Regenix Group Plc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Tissue Regenix Group Plc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | GBX45.35 Million | GBX43.24 Million | GBX38.27 Million | GBX34.13 Million | GBX36.73 Million |
| Total Current Assets | GBX21.27 Million | GBX19.09 Million | GBX18.32 Million | GBX16.29 Million | GBX20.09 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | GBX-1.00 Million | — | — | — |
| Net Receivables | GBX4.38 Million | GBX3.68 Million | GBX4.33 Million | GBX4.02 Million | GBX3.47 Million |
| Inventory | GBX14.01 Million | GBX10.36 Million | GBX9.05 Million | GBX7.18 Million | GBX7.07 Million |
| Property, Plant & Equipment | — | — | GBX8.94 Million | GBX9.10 Million | GBX5.71 Million |
| Goodwill | GBX11.59 Million | GBX11.59 Million | GBX9.63 Million | GBX8.55 Million | GBX8.61 Million |
| Total Liabilities | GBX16.29 Million | GBX13.89 Million | GBX13.00 Million | GBX9.47 Million | GBX8.88 Million |
| Total Current Liabilities | GBX6.16 Million | GBX4.74 Million | GBX6.64 Million | GBX3.22 Million | GBX3.26 Million |
| Long-term Debt | GBX9.73 Million | GBX5.53 Million | GBX5.26 Million | GBX4.46 Million | GBX2.79 Million |
| Net Debt | GBX8.60 Million | GBX4.75 Million | GBX3.04 Million | GBX175.72K | GBX-4.23 Million |
| Total Stockholder Equity | GBX29.82 Million | GBX30.15 Million | GBX31.25 Million | GBX25.35 Million | GBX28.46 Million |
| Retained Earnings | GBX-124.09 Million | GBX-123.76 Million | GBX-122.13 Million | GBX-84.75 Million | GBX-77.67 Million |
Tissue Regenix Group Plc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Tissue Regenix Group Plc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX-1.64 Million | GBX1.04 Million | GBX-1.29 Million | GBX-2.98 Million | GBX-6.05 Million |
| Capital Expenditures | GBX4.07 Million | GBX863.00K | GBX884.90K | GBX1.49 Million | GBX1.37 Million |
| Free Cash Flow | GBX-5.70 Million | GBX177.00K | GBX-2.29 Million | GBX-3.93 Million | GBX-6.84 Million |
| Investing Cash Flow | GBX-4.06 Million | GBX-837.00K | GBX-1.08 Million | GBX-2.04 Million | GBX-1.86 Million |
| Financing Cash Flow | GBX3.28 Million | GBX-1.51 Million | GBX910.00K | GBX-192.00K | GBX17.68 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | GBX363.00K | GBX342.00K | GBX249.00K | GBX110.00K | GBX-37.00K |
| Depreciation | GBX1.05 Million | GBX977.00K | GBX921.43K | GBX793.28K | GBX762.00K |
| Change in Cash | GBX-2.44 Million | GBX-1.30 Million | GBX-1.76 Million | GBX-5.26 Million | GBX9.85 Million |
Tissue Regenix Group Plc Earnings History — EPS Actual vs. Analyst Estimates
Track Tissue Regenix Group Plc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | -0.01 | 0.00 | — |
| Jun 04, 2025 | — | — | — |
| Mar 17, 2025 | — | — | — |
| Sep 10, 2024 | 0.00 | 0.00 | — |
| Mar 23, 2023 | 0.00 | 0.00 | — |
| Sep 07, 2022 | 0.00 | 0.00 | — |
| Apr 26, 2022 | 0.00 | 0.00 | — |
| Sep 08, 2021 | 0.00 | 0.00 | — |